Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Abstracto

Viral Hemorrhagic Fever Viruses such as Marburg Virus, Lassa Fever Virus & Dengue Virus

Emma Jonas

Lassa fever is a tremendous fitness danger to West African human populations with lots of lots of annual cases. There are no authorized scientific countermeasures presently available. Compassionate use of the antiviral drug ribavirin or transfusion of convalescent serum has resulted in blended success relying on when administered or the donor source, respectively. We until now recognized quite a few recombinant human monoclonal antibodies focused on the glycoprotein of Lassa virus with sturdy neutralization profiles in vitro. Here, we show brilliant therapeutic efficacy the use of first-in-class human antibodies in a guinea pig mannequin of Lassa contamination thereby supplying a promising therapy alternative. Lassa virus (LASV) reasons extreme hemorrhagic fever with excessive mortality, but no vaccine presently exists. Antibodies focused on viral attachment proteins are integral for safety towards many viral infections.